Recent successes with monoclonal antibody cocktails ZMapp(TM) and MIL77 against Ebola virus (EBOV) infections have reignited interest in antibody-based therapeutics. Since the production process for monoclonal antibodies can be prolonged and costly, alternative treatments should be investigated. We produced purified equine antisera from horses hyperimmunized with EBOV virus-like particles, and tested the post-exposure efficacy of the antisera in a mouse model of infection. BALB/c mice were given up to 2 mg of purified equine antisera per animal, at 30 minutes, 1 or 2 days post-infection (dpi), in which all animals survived. To decrease the possibility of serum sickness, the equine antisera was digested with pepsin to generate F(ab')2 fragments, with in vitro neutralizing activity comparable to whole immunoglobulin. Full protection was achieved with when treatment was initiated at 1 dpi, but the suboptimal protection observed with the 30 minute and 2 dpi groups demonstrate that in addition to virus neutralization, other Fc-dependent antibody mechanisms may also contribute to survival. Guinea pigs given 20 mg of antisera or F(ab')2 at or starting at 1 or 2 dpi were also fully protected from EBOV infection. These results justify future efficacy studies for purified equine products in NHPs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828711PMC
http://dx.doi.org/10.1038/srep24179DOI Listing

Publication Analysis

Top Keywords

purified equine
12
equine antisera
12
ebola virus
8
equine
5
antisera
5
treatment hyperimmune
4
hyperimmune equine
4
equine immunoglobulin
4
immunoglobulin immunoglobulin
4
immunoglobulin fragments
4

Similar Publications

Article Synopsis
  • Equine piroplasmosis, a disease caused by Babesia and Theileria parasites transmitted by ticks, poses significant clinical and economic threats globally, particularly to horses.
  • This research focused on analyzing the heat shock protein 70 kDa (hsp70) gene sequences of Theileria equi from infected horses in Brazil, using methods like PCR and phylogenetic analysis to explore genetic relationships among parasites.
  • Findings revealed two distinct genotypes of T. equi in Brazil, with hsp70 proving to be an effective molecular marker for distinguishing between closely related species and offering insights into the evolutionary history of these parasites.
View Article and Find Full Text PDF

Osteoarthritis (OA) is a debilitating disease that impacts millions of individuals and has limited therapeutic options. A significant hindrance to therapeutic discovery is the lack of in vitro OA models that translate reliably to in vivo preclinical animal models. An alternative to traditional inflammatory cytokine models is the matrikine stimulation model, in which fragments of matrix proteins naturally found in OA tissues and synovial fluid, are used to stimulate cells of the joint.

View Article and Find Full Text PDF

Premature acrosomal exocytosis in cryopreserved semen is one of the reasons attributed to low fertility among livestock. In the present study, we attempted to enhance the cryopreserved semen quality by selective removal of acrosome-reacted spermatozoa using FITC-PNA conjugated iron magnetic nanoparticles (MNPs). Further, the effect of nano purification on other sperm functional attributes was also assessed.

View Article and Find Full Text PDF

The rapid emergence of SARS-CoV-2 variants of concern (VoC) and the threat of future zoonotic sarbecovirus spillover emphasizes the need for broadly protective next-generation vaccines and therapeutics. We utilized SARS-CoV-2 spike ferritin nanoparticle (SpFN), and SARS-CoV-2 receptor binding domain ferritin nanoparticle (RFN) immunogens, in an equine model to elicit hyperimmune sera and evaluated its sarbecovirus neutralization and protection capacity. Immunized animals rapidly elicited sera with the potent neutralization of SARS-CoV-2 VoC, and SARS-CoV-1 pseudoviruses, and potent binding against receptor binding domains from sarbecovirus clades 1b, 1a, 2, 3, and 4.

View Article and Find Full Text PDF

Identification of three novel linear B-cell epitopes on VP7 of African horse sickness virus using monoclonal antibodies.

Vet Microbiol

November 2024

State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730000, China; Gansu Province Research Center for Basic Disciplines of Pathogen Biology, Lanzhou 730046, China. Electronic address:

Article Synopsis
  • * The research involved creating a recombinant version of the VP7 protein in E. coli and identifying four monoclonal antibodies that recognize specific B-cell epitopes on this protein through various immunological methods.
  • * Findings revealed conserved epitopes among different AHSV serotypes, which could aid in developing better diagnostic tools and potential vaccine strategies against AHS.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!